Cargando…

Sacral neuromodulation in patients with refractory overactive bladder symptoms after failed Botulinum toxin therapy: Results in a large cohort of patients

AIMS: Sacral neuromodulation (SNM) and Botulinum toxin A (BoNT‐A) injections are well‐known third‐line treatment options in patients with refractory overactive bladder (OAB). Our aim is to evaluate the success rate of SNM in patients who received prior therapy with BoNT‐A injections. METHODS: All pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reekmans, Mathias, Janssen, Janine M. W., Vrijens, Desiree M. J., Smits, Martijn A. C., van Koeveringe, Gommert A., Van Kerrebroeck, Philip E. V. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Basic Science Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360188/ https://www.ncbi.nlm.nih.gov/pubmed/33829519 http://dx.doi.org/10.1002/nau.24670

Ejemplares similares

The value of urodynamic tools to guide patient selection in sacral neuromodulation
por: Drossaerts, Jamie, et al.
Publicado: (2015)

Overactive Bladder Syndrome and the Potential Role of Prostaglandins and Phosphodiesterases: An Introduction
por: Rahnama'i, Mohammad Sajjad, et al.
Publicado: (2013)

A comparative study between sacral neuromodulation and intravesical botulinum toxin injection for patients with refractory overactive bladder
por: Al-Azzawi, Issam S., et al.
Publicado: (2020)

Stimulation Parameters for Sacral Neuromodulation on Lower Urinary Tract and Bowel Dysfunction–Related Clinical Outcome: A Systematic Review
por: Assmann, Roman, et al.
Publicado: (2020)

Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation
por: Trinh, Hamilton, et al.
Publicado: (2019)

Sacral Neuromodulation for Lower Urinary Tract and Bowel Dysfunction in Animal Models: A Systematic Review With Focus on Stimulation Parameter Selection
por: Douven, Perla, et al.
Publicado: (2020)

Advances in the role of sacral nerve neuromodulation in lower urinary tract symptoms
por: Van Kerrebroeck, Philip E. V.
Publicado: (2010)

Two‐year safety and efficacy outcomes for the treatment of overactive bladder using a long‐lived rechargeable sacral neuromodulation system
por: Blok, Bertil, et al.
Publicado: (2020)

Multidisciplinary treatment for functional urological disorders with psychosomatic comorbidity in a tertiary pelvic care center—A retrospective cohort study
por: van Knippenberg, Vera, et al.
Publicado: (2022)

Sacral neuromodulation in overactive bladder: a review and current perspectives
por: Sukhu, Troy, et al.
Publicado: (2016)

New Technologies and Applications in Sacral Neuromodulation: An Update
por: De Wachter, Stefan, et al.
Publicado: (2019)

Sacral neuromodulation as a treatment for neuropathic clitoral pain after abdominal hysterectomy
por: Marcelissen, Tom, et al.
Publicado: (2010)

Assessment of Brainstem Functional Organization in Healthy Adults and Overactive Bladder Patients Using Ultra-High Field fMRI
por: Fernández Chadily, Susana, et al.
Publicado: (2023)

Effects of Acute Sacral Neuromodulation at Different Frequencies on Bladder Overactivity in Pigs
por: Li, Xing, et al.
Publicado: (2017)

Acute effect of sacral neuromodulation for treatment of detrusor overactivity on urodynamic parameters
por: Groenendijk, Ilse M., et al.
Publicado: (2019)

Replacement Adaptor 09106 for patients with a dynamic graciloplasty or patients with sacral neuromodulation and abdominal implantable pulse generators: a retrospective, single centre, Stage 2a/2b development IDEAL case series
por: Assmann, Roman, et al.
Publicado: (2022)

Patient‐tailored healthcare and tibial nerve neuromodulation in the treatment of patients with overactive bladder symptoms
por: te Dorsthorst, Manon, et al.
Publicado: (2022)

Botulinum Toxin in Neurogenic Detrusor Overactivity
por: D'Ancona, Carlos Arturo Levi, et al.
Publicado: (2012)

Effects of Acute Sacral Neuromodulation at Different Pulse Widths on Bladder Overactivity in Pigs
por: Cong, Huiling, et al.
Publicado: (2019)

Sacral neuromodulation for overactive bladder using the InterStim and BetterStim systems
por: Meng, Lingfeng, et al.
Publicado: (2022)

A new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies
por: van Renterghem, Koenraad, et al.
Publicado: (2009)

Rationale for the Use of Prostaglandins and Phosphodiesterase Inhibitors in the Treatment of Functional Bladder Disorders
por: Rahnama'i, Mohammad Sajjad, et al.
Publicado: (2013)

Sleep disturbance changes in women after treatment of refractory overactive bladder with sacral neuromodulation
por: Sanderson, Derrick J., et al.
Publicado: (2020)

Botulinum toxin A for the Treatment of Overactive Bladder
por: Hsieh, Po-Fan, et al.
Publicado: (2016)

Refractory overactive bladder patients who chose sacral neuromodulation therapy after failed OnabotulinumtoxinA treatment: A systematic review and meta-analysis
por: Yang, Guang, et al.
Publicado: (2020)

Sacral neuromodulation in sphincteric disorders
por: Lavano, A
Publicado: (2010)

The use of botulinum toxin for the treatment of overactive bladder syndrome
por: Orasanu, Bogdan, et al.
Publicado: (2013)

The effect of indomethacin on the muscarinic induced contractions in the isolated normal guinea pig urinary bladder
por: Rahnama’i, Mohammad S, et al.
Publicado: (2013)

Botulinum toxin-A for the treatment of overactive bladder: UK contributions
por: Seth, JH, et al.
Publicado: (2013)

Do Failure of Posterior Tibial Nerve Stimulation Precludes to Use Sacral Neuromodulation in Patient With Overactive Bladder?
por: Berthelot, Louis-Paul, et al.
Publicado: (2019)

Variable frequency stimulation of sacral neuromodulation in black-zone overactive bladder patients: a case report
por: Meng, Lingfeng, et al.
Publicado: (2020)

Axonics Sacral Neuromodulation System for Treating Refractory Overactive Bladder: A NICE Medical Technologies Guidance
por: Poole, Ruth Louise, et al.
Publicado: (2021)

Reprogramming Sacral Neuromodulation for Sub‐Optimal Outcomes: Evidence and Recommendations for Clinical Practice
por: Dudding, Thomas C., et al.
Publicado: (2021)

Parcellation of human periaqueductal gray at 7‐T fMRI in full and empty bladder state: The foundation to study dynamic connectivity changes related to lower urinary tract functioning
por: de Rijk, Mathijs M., et al.
Publicado: (2021)

Emerging treatments for overactive bladder: clinical potential of botulinum toxins
por: Tincello, Douglas G, et al.
Publicado: (2014)

Sacral neuromodulation: Therapy evolution
por: Thompson, Jannah H., et al.
Publicado: (2010)

Sacral neuromodulation - when and for who
por: Mass-Lindenbaum, Marcelo, et al.
Publicado: (2021)

Medium-term outcomes of sacral neuromodulation in patients with refractory overactive bladder: A retrospective single-institution study
por: Kaaki, Bilal, et al.
Publicado: (2020)

Intermediate-term results of a prospective, multicenter study on remote programming sacral neuromodulation for refractory overactive bladder
por: Zhang, Yaoguang, et al.
Publicado: (2021)

Botulinum toxin in spinal cord injury patients with neurogenic detrusor overactivity
por: Cho, Young Sam, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_boho5ig6n5mch6br55matv7142